Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F P Tally

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
The Annals of Otology, Rhinology & Laryngology. Supplement|September 1, 1991
Microbiology and antibiotic resistance in odontogenic infectionsS L Gorbach, W C Gilmore, N V Jacobus, et al.
Annals of Internal Medicine|October 1, 1975
Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organismsF P Tally, T J Louie, W M Weinstein, et al.
Diagnostic Microbiology and Infectious Disease|June 1, 1987
Clinical importance of cefoxitin-resistant Bacteroides fragilis isolatesV M Bieluch, G J Cuchural, D R Snydman, et al.
Journal of Bacteriology|November 1, 1982
Hybridization studies reveal homologies between pBF4 and pBFTM10, Two clindamycin-erythromycin resistance transfer plasmids of Bacteroides fragilisM J Shimell, C J Smith, F P Tally, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1980
Bacteroides bivius and Bacteroides disiens in obstetrical patients: clinical findings and antimicrobial susceptibilitiesD R Snydman, F P Tally, R Knuppel, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1986
Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infectionsF P Tally, J M Kellum, J L Ho, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1974
Susceptibility of Clostridium ramosum to antimicrobial agentsF P Tally, A Y Armfield, V R Dowell, et al.
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivoN A Kuck, P J Petersen, W J Weiss, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
Once-daily dosing in dogs optimizes daptomycin safetyF B Oleson, C L Berman, J B Kirkpatrick, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1993
In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclinesR T Testa, P J Petersen, N V Jacobus, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
The Annals of Otology, Rhinology & Laryngology. Supplement|September 1, 1991
Microbiology and antibiotic resistance in odontogenic infectionsS L Gorbach, W C Gilmore, N V Jacobus, et al.
Annals of Internal Medicine|October 1, 1975
Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organismsF P Tally, T J Louie, W M Weinstein, et al.
Diagnostic Microbiology and Infectious Disease|June 1, 1987
Clinical importance of cefoxitin-resistant Bacteroides fragilis isolatesV M Bieluch, G J Cuchural, D R Snydman, et al.
Journal of Bacteriology|November 1, 1982
Hybridization studies reveal homologies between pBF4 and pBFTM10, Two clindamycin-erythromycin resistance transfer plasmids of Bacteroides fragilisM J Shimell, C J Smith, F P Tally, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1980
Bacteroides bivius and Bacteroides disiens in obstetrical patients: clinical findings and antimicrobial susceptibilitiesD R Snydman, F P Tally, R Knuppel, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1986
Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infectionsF P Tally, J M Kellum, J L Ho, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1974
Susceptibility of Clostridium ramosum to antimicrobial agentsF P Tally, A Y Armfield, V R Dowell, et al.
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivoN A Kuck, P J Petersen, W J Weiss, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
Once-daily dosing in dogs optimizes daptomycin safetyF B Oleson, C L Berman, J B Kirkpatrick, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1993
In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclinesR T Testa, P J Petersen, N V Jacobus, et al.
Pageof 13